Identification of a bradykinin-generating hypotensive substance in plasma protein fraction: prekallikrein activator (PKA-beta-Xiia). 1983

J C Bakker, and A de Vries-van Rossen, and H Radema, and W Bleeker, and J G Ufkes, and R F van Rosevelt, and J A van Mourik

UI MeSH Term Description Entries
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D001920 Bradykinin A nonapeptide messenger that is enzymatically produced from KALLIDIN in the blood where it is a potent but short-lived agent of arteriolar dilation and increased capillary permeability. Bradykinin is also released from MAST CELLS during asthma attacks, from gut walls as a gastrointestinal vasodilator, from damaged tissues as a pain signal, and may be a neurotransmitter. Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg,Bradykinin Acetate, (9-D-Arg)-Isomer,Bradykinin Diacetate,Bradykinin Hydrochloride,Bradykinin Triacetate,Bradykinin, (1-D-Arg)-Isomer,Bradykinin, (2-D-Pro)-Isomer,Bradykinin, (2-D-Pro-3-D-Pro-7-D-Pro)-Isomer,Bradykinin, (2-D-Pro-7-D-Pro)-Isomer,Bradykinin, (3-D-Pro)-Isomer,Bradykinin, (3-D-Pro-7-D-Pro)-Isomer,Bradykinin, (5-D-Phe)-Isomer,Bradykinin, (5-D-Phe-8-D-Phe)-Isomer,Bradykinin, (6-D-Ser)-Isomer,Bradykinin, (7-D-Pro)-Isomer,Bradykinin, (8-D-Phe)-Isomer,Bradykinin, (9-D-Arg)-Isomer,Arg Pro Pro Gly Phe Ser Pro Phe Arg
D005174 Factor XII Stable blood coagulation factor activated by contact with the subendothelial surface of an injured vessel. Along with prekallikrein, it serves as the contact factor that initiates the intrinsic pathway of blood coagulation. Kallikrein activates factor XII to XIIa. Deficiency of factor XII, also called the Hageman trait, leads to increased incidence of thromboembolic disease. Mutations in the gene for factor XII that appear to increase factor XII amidolytic activity are associated with HEREDITARY ANGIOEDEMA TYPE III. Coagulation Factor XII,Hageman Factor,Factor 12,Factor Twelve
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.
D015956 Factor XIIa Activated form of factor XII. In the initial event in the intrinsic pathway of blood coagulation, kallikrein (with cofactor HIGH MOLECULAR WEIGHT KININOGEN) cleaves factor XII to XIIa. Factor XIIa is then further cleaved by kallikrein, plasmin, and trypsin to yield smaller factor XII fragments (Hageman-Factor fragments). These fragments increase the activity of prekallikrein to kallikrein but decrease the procoagulant activity of factor XII. Coagulation Factor XIIa,Factor XII, Activated,Activated Factor XII,Blood Coagulation Factor XII, Activated,Factor 12A,Factor Twelve A,Hageman-Factor Fragments,Prekallikrein Activator,Activator, Prekallikrein,Factor XIIa, Coagulation,Fragments, Hageman-Factor,Hageman Factor Fragments

Related Publications

J C Bakker, and A de Vries-van Rossen, and H Radema, and W Bleeker, and J G Ufkes, and R F van Rosevelt, and J A van Mourik
January 1980, Developments in biological standardization,
J C Bakker, and A de Vries-van Rossen, and H Radema, and W Bleeker, and J G Ufkes, and R F van Rosevelt, and J A van Mourik
May 1984, Rinsho byori. The Japanese journal of clinical pathology,
J C Bakker, and A de Vries-van Rossen, and H Radema, and W Bleeker, and J G Ufkes, and R F van Rosevelt, and J A van Mourik
January 1990, Medycyna doswiadczalna i mikrobiologia,
J C Bakker, and A de Vries-van Rossen, and H Radema, and W Bleeker, and J G Ufkes, and R F van Rosevelt, and J A van Mourik
March 1982, The Annals of thoracic surgery,
J C Bakker, and A de Vries-van Rossen, and H Radema, and W Bleeker, and J G Ufkes, and R F van Rosevelt, and J A van Mourik
July 1978, The New England journal of medicine,
J C Bakker, and A de Vries-van Rossen, and H Radema, and W Bleeker, and J G Ufkes, and R F van Rosevelt, and J A van Mourik
January 1979, Developments in biological standardization,
J C Bakker, and A de Vries-van Rossen, and H Radema, and W Bleeker, and J G Ufkes, and R F van Rosevelt, and J A van Mourik
February 1983, The Journal of laboratory and clinical medicine,
J C Bakker, and A de Vries-van Rossen, and H Radema, and W Bleeker, and J G Ufkes, and R F van Rosevelt, and J A van Mourik
June 1985, British journal of haematology,
J C Bakker, and A de Vries-van Rossen, and H Radema, and W Bleeker, and J G Ufkes, and R F van Rosevelt, and J A van Mourik
October 1982, British journal of haematology,
J C Bakker, and A de Vries-van Rossen, and H Radema, and W Bleeker, and J G Ufkes, and R F van Rosevelt, and J A van Mourik
January 1987, Medycyna doswiadczalna i mikrobiologia,
Copied contents to your clipboard!